Archives — Current Month (25)

Atlantic Gold: Constructing MRC Is Just the Start of This Growth Story (02/21/2017)

The Critical Investor profiles Atlantic Gold, which expects to commission its Moose River gold mine in Nova Scotia by the end of this year.

more>

Jack Chan: Buy Zones in an Oil Bull Market (02/18/2017)

Technical analyst Jack Chan charts the latest moves in energy market, noting a major buy signal.

more>

Jack Chan's Weekly Gold and Silver Update (02/18/2017)

Technical analyst Jack Chan charts the latest moves in the precious metals sector.

more>

Investing in Life Sciences Under the Trump Presidency (02/16/2017)

Stocks in all areas of life sciences including biotech to pharma have been on a roller coaster since Donald Trump won the election in November. Wealth advisor Kristin McFarland discusses the big picture for pharmaceutical investment under the new administration.

more>

TerraX Advancing Yellowknife, a 'World-Class Exploration Project' (02/16/2017)

TerraX has been moving full speed ahead exploring its large land package at the Yellowknife City Gold project, an area with historic high-grade mines, that experts predict could become a district-scale project.

more>

Four Extraction Companies That Top BT Global Growth's List (02/14/2017)

BT Global Growth's game plan is to go long and short on a wide range of investments, but in this interview with The Gold Report, Paul Beattie, cofounder and managing director of the hedge fund, focuses on four undervalued extraction companies on which the fund is definitely long.

more>

Remembering the Genius of Hunter S. Thompson (02/13/2017)

Precious metals expert Michael Ballanger ponders the timelessness of Hunter S. Thompson's "blistering attacks on the status quo" and their applicability to today's political landscape. He also reminds us of the "incredibly bullish" fundamentals for silver and lays out the evidence for why this precious metal is on its way to $25/ounce by mid-year.

more>

Jack Chan Finds Data Supportive of Higher Oil Prices (02/11/2017)

Technical Analyst Jack Chan reads the charts and sees a major buy signal for energy.

more>

Jack Chan's Weekly Update on Gold and Silver (02/11/2017)

Jack Chan charts both long- and short-term buy signals for gold and silver.

more>

MGX Shareholders Ride a Rollercoaster (02/10/2017)

Bob Moriarty of 321 Gold chronicles MGX Minerals' wild ride from $0.69 to $2.75 to $0.92 in three weeks.

more>

Five Companies Positioned for Healthy Returns as Energy Markets Recover (02/09/2017)

Volatility in the oil and gas markets continues, with prices plunging yet again in the recent chaos surrounding Greece's default negotiations and other global political uncertainties. But a rebound is inevitable, and Mackie Research's Bill Newman has his eye on companies that have managed to grow, step by step, even in hard times. In this interview with The Energy Report, Newman identifies companies with individual stories that will, in the end, defy the trend.

more>

RJK and Winston Hit Big Gold (02/09/2017)

Bob Moriarty of 321 Gold profiles two gold explorers, RJK Explorations and Winston Gold, that he sees as low-risk, high-potential stocks.

more>

Regeneus Hits the Fast Track with Major Japanese Partnership (02/08/2017)

Regeneus, an Australian regenerative medicine company, has entered into a collaboration with a major Japanese firm to manufacture its stem cell therapy Progenza, a move that may accelerate approval and that has a pair of analysts optimistic about the company's future.

more>

Terraco Gold Expands Royalty on Spring Valley Gold Project in Nevada (02/08/2017)

After a relatively long period without significant news, Terraco Gold seems to have shifted a gear now, so The Critical Investor sat down with CEO Todd Hilditch for a company update.

more>

Trevali Is in Position to Benefit from Strong Zinc Fundamentals (02/07/2017)

Trevali Mining is transitioning to an owner-operator model at its Caribou zinc mine in New Brunswick, Canada, and analysts note that the company is positioned to take advantage of strong zinc fundamentals.

more>

But What About that 'Big, Ugly, Red Candle'? (02/07/2017)

Precious metals expert Michael Ballanger discusses why technical analysis does not work in the precious metals arena.

more>

Luminor Drives the Scout DS Forward (02/06/2017)

Veteran investor Bob Moriarty discusses Luminor Medical Technologies, whose Scout DS technology offers a noninvasive diabetic screen, measuring blood-sugar levels without taking blood.

more>

Major Banks Are Now Bullish for the First Time in Close to a Decade (02/06/2017)

Chinese and European economic activities are finally showing signs of strength, and in 2017, any severe corrections should be viewed as opportunities to position more strategically for long-term gains, says Lior Gantz, editor of Wealth Research Group.

more>

Jack Chan: This Past Week in Gold (02/04/2017)

Technical analyst Jack Chan charts the latest moves in the gold and silver markets.

more>

The Future of Cannabis Investing (02/03/2017)

The cannabis industry attained new highs in 2016, paving the way for some big changes this year, says Tom Beck, senior editor of Portfolio Wealth Global.

more>

Pershing Gold Is Laser-Focused on Restarting Relief Canyon (02/02/2017)

Pershing Gold has been going full speed ahead to advance the Relief Canyon mine in Nevada, leading some analysts to speculate that production could begin by the end of the year.

more>

Victoria Gold's Eagle Is Getting Ready to Soar (02/02/2017)

Victoria Gold's Eagle project in the Yukon moved closer to production with the announcement of a debt facility to fund construction.

more>

ContraVir's Hep B Drug Could Be a Game Changer (02/01/2017)

In light of a Q4/16 announcement by ContraVir Pharmaceuticals about the effectiveness of its compound targeting the hepatitis B virus (HBV), several analysts believe expanding its Phase 2a dose escalation trial could lead to positive results for a population that represents an unmet medical need, as well as for the company.

more>

Companies Flocking to Japan for Biotech Deals (02/01/2017)

For the last two years, Japan has been at the forefront of accelerated approval for regenerative medicine products and has seen lots of licensing and contract manufacturing deals and M&A activity. Tokyo-based Colin Lee Novick, managing director of CJ PARTNERS, surveys the landscape, discussing recent tie-ups, the effects of the recently passed 21st Century Cures Act in the U.S., and what may lie ahead.

more>

BonTerra Hits Big Gold Numbers (02/01/2017)

Bob Moriarty of 321 Gold provides an update on BonTerra Resources after the release of high-grade drill results.

more>

More Archives

2017Jan

2016Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2015Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2014Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2013Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2012Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec